分子バイオマーカーと診断のジャーナル

Biomarkers in Identification of COVID-19

Abstract

Pritisnigdha Pattnaik

Wuhan, the most populous city of central China, developed a mysterious circumstance of pneumonia on December 2019, a series of acute respiratory illnesses were reported. The scientists of China recognized this as a novel coronavirus on January 2020. On February 2020, the coronavirus disease spread globally. People infected with SARS-CoV-2, the cause ofCOVID-19, react contrarily. Some patients were asymptomatic, some require to be hospitalized and, for some, the disease became lethal. Hence, it is vital to establish a patient's state in an appropriate method. Biomarkers are quantitative measurements used clinically for many conditions reflecting pathological development.